Suchen
CareDx Inc
CDNAZur Watchlist hinzufügen
29.154USD
-0.096-0.33%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
1.50BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über CareDx Inc Unternehmen
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.
CareDx Inc Informationen
BörsenkürzelCDNA
Name des UnternehmensCareDx Inc
IPO-datumJul 17, 2014
CEOHanna (John W)
Anzahl der mitarbeiter644
WertpapierartOrdinary Share
GeschäftsjahresendeJul 17
Addresse8000 Marina Blvd
StadtBRISBANE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94005
Telefon14152872300
Websitehttps://www.caredx.com/
BörsenkürzelCDNA
IPO-datumJul 17, 2014
CEOHanna (John W)
Führungskräfte von CareDx Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Peter Maag, Ph.D.
Dr. Peter Maag, Ph.D.
Independent Director
Independent Director
296.74K
-0.52%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
157.13K
+6.23%
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
152.96K
+6.40%
Ms. Christine M. Cournoyer
Ms. Christine M. Cournoyer
Independent Director
Independent Director
46.84K
+20.91%
Mr. William A. (Bill) Hagstrom
Mr. William A. (Bill) Hagstrom
Independent Director
Independent Director
43.41K
--
Mr. Jeffrey Adam Novack
Mr. Jeffrey Adam Novack
General Counsel, Secretary
General Counsel, Secretary
37.72K
-3.42%
Mr. Suresh Gunasekaran
Mr. Suresh Gunasekaran
Director
Director
37.25K
+26.30%
Ms. Jessica Meng
Ms. Jessica Meng
Chief Commercial Officer
Chief Commercial Officer
28.79K
-25.66%
Mr. Nathan Smith
Mr. Nathan Smith
Chief Financial Officer
Chief Financial Officer
8.17K
-867.03%
Mr. George W. Bickerstaff, III
Mr. George W. Bickerstaff, III
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Peter Maag, Ph.D.
Dr. Peter Maag, Ph.D.
Independent Director
Independent Director
296.74K
-0.52%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
157.13K
+6.23%
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
152.96K
+6.40%
Ms. Christine M. Cournoyer
Ms. Christine M. Cournoyer
Independent Director
Independent Director
46.84K
+20.91%
Mr. William A. (Bill) Hagstrom
Mr. William A. (Bill) Hagstrom
Independent Director
Independent Director
43.41K
--
Mr. Jeffrey Adam Novack
Mr. Jeffrey Adam Novack
General Counsel, Secretary
General Counsel, Secretary
37.72K
-3.42%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von CareDx Inc?
Die fünf größten Anteilseigner von CareDx Inc sind: Dr. Peter Maag, Ph.D.
Wie viele Institutionen halten Anteile an CareDx Inc (CDNA)?
Mit Stand vom 2026Q1 halten 469 Institutionen Anteile an CareDx Inc, mit einem Gesamtmarktwert von etwa 52.46M, was 101.54% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -9782235.00 gestiegen.
Was ist die größte Einnahmequelle von CareDx Inc?
Am 2026Q1 erzielte das Geschäft mit Testing Service revenue für CareDx Inc den höchsten Umsatz in Höhe von 274.50M, was 72.27% des Gesamtumsatzes entspricht.